Abbott Laboratories (ABT)

Accounts Payable

$4.79B

Quarterly · Period ending: · USD

ABT logo

ABT Accounts Payable

Latest reported$4.79B
ABT Quarterly Accounts Payable ($0.00 → $4.79B)
High-resolution chart · PNG

ABT accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
1,517,695,000
1,453,288,000
1,355,985,000
1,263,700,000
1,480,079,000
1,203,779,000
1,226,854,000
1,191,383,000
830,748,000
1,058,172,000
1,057,400,000
922,341,000
932,490,000
942,589,000
1,001,100,000
819,885,000
911,436,000
966,853,000
923,000,000
788,092,000
806,290,000
709,148,000
755,921,000
665,932,000
754,266,000
678,807,000
671,100,000
592,479,000
724,472,000
602,829,000
638,509,000
509,600,000
485,600,000
501,600,000
597,200,000
443,000,000
437,300,000
432,700,000
522,400,000
363,500,000
372,800,000
355,100,000
351,200,000
313,400,000
310,300,000
322,000,000
309,800,000
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.